Global SRS Treatment Planning Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

SRS Treatment Planning Systems Market Size

• The global SRS treatment planning systems market size was valued at USD 1.9 billion in 2025 and is expected to reach USD 3.6 billion by 2033, at a CAGR of 8.3% during the forecast period
• Growth is driven by increasing adoption of precision oncology and non-invasive brain tumor treatments
• Rising incidence of neurological disorders and cancer cases is accelerating demand for advanced treatment planning solutions
• Integration of AI-based imaging and real-time dose optimization is further supporting market expansion

SRS Treatment Planning Systems Market Analysis

• SRS treatment planning systems, which provide capabilities such as high-precision dose calculation, multimodal imaging integration, automated contouring, and adaptive radiation optimization, are becoming essential components across radiation oncology practices, particularly in the treatment of brain tumors, spine lesions, lung cancer, and other complex indications due to their ability to enhance targeting accuracy, treatment safety, and clinical efficiency
• The escalating demand for SRS treatment planning systems is primarily driven by the increasing global incidence of cancer and neurological disorders, growing adoption of non-invasive and high-precision radiotherapy techniques, rising integration of artificial intelligence in treatment planning, and expanding investments in advanced oncology infrastructure, along with the need to improve patient outcomes while minimizing radiation exposure to surrounding healthy tissues
• North America dominated the SRS treatment planning systems market with the largest revenue share of approximately 38.2% in 2025, supported by well-established healthcare infrastructure, high penetration of advanced radiotherapy technologies, strong presence of leading market players, and increasing adoption of stereotactic radiosurgery procedures, particularly in the United States
• Asia-Pacific is expected to be the fastest growing region in the SRS treatment planning systems market during the forecast period due to rising cancer burden, increasing healthcare expenditure, expanding number of radiotherapy centers, and growing awareness regarding advanced treatment options across countries such as China, India, and Japan
• The software segment dominated the SRS treatment planning systems market with a market share of approximately 62.5% in 2025, driven by increasing demand for advanced dose planning algorithms, workflow automation, and seamless integration with imaging systems, along with the growing need for precise, efficient, and personalized radiation treatment planning in modern oncology practices.

Report Scope and SRS Treatment Planning Systems Market Segmentation         

SRS Treatment Planning Systems Market Trends

“Growing Integration of Artificial Intelligence and Automation in Treatment Planning””

• A significant and accelerating trend in the global SRS treatment planning systems market is the increasing integration of artificial intelligence and automation technologies that enhance treatment accuracy, reduce planning time, and improve clinical outcomes across radiation oncology workflows
• For instance, companies are increasingly developing advanced treatment planning solutions with AI-based contouring, automated dose optimization, and real-time imaging integration to improve precision in stereotactic radiosurgery procedures
• Technological advancements in software algorithms and imaging integration are enabling the development of treatment planning systems with improved accuracy, faster processing capabilities, and better compatibility with multiple radiotherapy platforms, helping healthcare providers enhance treatment efficiency
• The increasing adoption of precision oncology and personalized treatment approaches is supporting the demand for advanced planning systems that improve patient-specific treatment accuracy and clinical decision-making
• This trend toward intelligent and high-performance planning systems is reshaping industry expectations for treatment quality, workflow efficiency, and patient safety across hospitals and cancer treatment center
• The demand for advanced SRS treatment planning systems with improved automation, interoperability, and data-driven capabilities is growing rapidly across both developed and emerging healthcare markets
• Increasing adoption of digital healthcare solutions and integration with cloud-based platforms is gaining traction due to rising demand for remote access, collaboration, and efficient data management across oncology networks.

SRS Treatment Planning Systems Market Dynamics

Driver

“Rising Demand for Precision and Minimally Invasive Cancer Treatment”

• The increasing demand for high-precision, non-invasive cancer treatment solutions, coupled with the rising global burden of cancer and neurological disorders, is a major driver fueling the growth of the SRS treatment planning systems market globally
• for instance, healthcare systems in regions such as North America and Europe are encouraging the adoption of advanced radiotherapy technologies to improve treatment outcomes and reduce patient recovery time
• As healthcare providers focus more on improving clinical accuracy and treatment efficiency, SRS treatment planning systems offer precise tumor targeting, reduced radiation exposure to healthy tissues, and improved overall treatment effectiveness compared to conventional radiotherapy methods
• Furthermore, the growing shift toward personalized medicine and advanced oncology care, supported by increasing healthcare investments and technological advancements, is driving the adoption of SRS treatment planning systems across healthcare facilities
• The versatility of these systems across applications such as brain tumor treatment, spine radiosurgery, and stereotactic body radiotherapy is driving widespread adoption in modern oncology practices
• Expanding healthcare infrastructure and rising healthcare expenditure in emerging economies are further supporting market expansion through increased access to advanced cancer treatment technologies
• Government initiatives and healthcare policies promoting advanced cancer care and digital health solutions are accelerating investments and adoption of SRS treatment planning systems globally

Restraint/Challenge

“High Cost and Technical Complexity of Advanced Systems”

• Challenges related to the high cost of SRS treatment planning systems and their integration with advanced radiotherapy infrastructure pose significant barriers to large-scale adoption, particularly in developing regions
• For instance, implementation of these systems requires significant capital investment in software, hardware compatibility, and skilled workforce, which can limit adoption in cost-sensitive healthcare settings
• Addressing these challenges through technological advancements, cost optimization strategies, and scalable solutions is critical for improving market accessibility and penetration
• While demand for advanced radiotherapy solutions is increasing, complexities related to system interoperability, data integration, and workflow management can restrict efficient utilization in some healthcare facilities
• Overcoming these challenges through continuous innovation, improved user interfaces, and enhanced system integration capabilities will be essential for long-term market growth
• Stringent regulatory requirements and compliance standards can also increase development timelines and operational complexity for manufacturers, potentially impacting product deployment and adoption rates

SRS Treatment Planning Systems Market Scope

The market is segmented on the basis of product, source, form, and application.

• By Component

On the basis of component, the global SRS treatment planning systems market is segmented into software and services. The software segment dominated the market with the largest revenue share of approximately 62.5% in 2025, driven by its critical role in dose calculation, treatment simulation, imaging integration, and workflow automation in radiation oncology. These systems enable high precision in treatment planning and improve clinical efficiency, making them indispensable in modern radiotherapy practices. Continuous advancements in artificial intelligence, automated contouring, and adaptive planning are further strengthening the dominance of the software segment globally.

The services segment is expected to witness the fastest growth during the forecast period, fueled by increasing demand for system maintenance, training, upgrades, and consulting services. As healthcare facilities adopt more advanced and complex planning systems, the need for technical support and optimization services is rising significantly, further accelerating segment growth.

• By Deployment Mode

On the basis of deployment mode, the market is segmented into on-premise, cloud-based, and hybrid solutions. The on-premise segment dominated the market with the largest revenue share in 2025 due to higher data security, regulatory compliance, and widespread adoption across hospitals with established IT infrastructure. These systems provide greater control over patient data and are preferred by large healthcare institutions.

The cloud-based segment is expected to witness the fastest growth during the forecast period, driven by increasing demand for scalability, remote accessibility, and collaborative treatment planning. The ability to integrate data across multiple locations and improve workflow efficiency is accelerating adoption of cloud-based platforms in oncology centers globally..

• By Treatment Type

On the basis of treatment type, the market is segmented into brain tumors, spine tumors, lung cancer, prostate cancer, liver cancer, and others. The brain tumor segment dominated the market with the largest revenue share of approximately 34.8% in 2025, driven by the widespread use of stereotactic radiosurgery for intracranial lesions and neurological conditions. High precision requirements and increasing prevalence of brain-related disorders are supporting segment dominance.

The lung cancer segment is expected to witness the fastest growth during the forecast period due to rising global incidence of lung cancer and increasing adoption of stereotactic body radiotherapy for early-stage tumors. Advancements in motion management and imaging technologies are further supporting growth in this segment.

• By Technology

On the basis of technology, the market is segmented into linear accelerator (LINAC)-based planning, Gamma Knife planning, CyberKnife planning, proton therapy planning, and photon-based SRS. The LINAC-based planning segment dominated the market with the largest revenue share of approximately 36.7% in 2025 due to its widespread availability, versatility, and ability to treat a broad range of cancer types. Its integration with advanced imaging and planning software further enhances treatment accuracy and efficiency.

The proton therapy planning segment is expected to witness the fastest growth during the forecast period, driven by its superior dose distribution capabilities and ability to minimize radiation exposure to surrounding healthy tissues. Increasing investments in proton therapy centers and growing demand for advanced cancer treatment solutions are accelerating segment growth.

• By Application

On the basis of application, the market is segmented into stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), image-guided radiotherapy (IGRT), and adaptive radiotherapy. The stereotactic radiosurgery segment dominated the market with the largest revenue share of approximately 41.3% in 2025, supported by its extensive use in treating brain tumors and other neurological conditions with high precision and minimal invasiveness.

The adaptive radiotherapy segment is expected to witness the fastest growth during the forecast period due to increasing adoption of real-time treatment adjustments and personalized therapy approaches. Technological advancements enabling dynamic treatment planning are significantly contributing to segment expansion.

• By End User

On the basis of end user, the market is segmented into hospitals, cancer treatment centers, ambulatory surgical centers, and research and academic institutes. The hospitals segment dominated the market with the largest revenue share of approximately 48.6% in 2025 due to high patient volume, availability of advanced infrastructure, and adoption of integrated radiotherapy solutions.

The cancer treatment centers segment is expected to witness the fastest growth during the forecast period, driven by increasing specialization in oncology services, rising number of dedicated radiotherapy centers, and growing demand for advanced treatment planning systems.

SRS Treatment Planning Systems Market Regional Analysis

• North America dominated the SRS treatment planning systems market with the largest revenue share of approximately 38.2% in 2025, supported by advanced healthcare infrastructure, high adoption of stereotactic radiosurgery technologies, and strong presence of leading market players. The region benefits from well-established oncology centers, increasing utilization of precision radiotherapy, and continuous technological advancements in treatment planning systems, particularly in the United States and Canada.
• Manufacturers and healthcare providers in the region place significant emphasis on technological innovation, integration of artificial intelligence in treatment planning, and adoption of advanced radiotherapy solutions, leading to widespread utilization of SRS treatment planning systems across hospitals and specialized cancer treatment centers. This strong market position is further supported by favorable reimbursement frameworks, increasing healthcare expenditure, and ongoing investments in cancer care infrastructure, establishing these systems as critical components in modern oncology practices.

U.S. SRS Treatment Planning Systems Market Insight

The U.S. SRS treatment planning systems market captured the largest revenue share within North America in 2025, driven by high adoption of advanced radiotherapy technologies, strong presence of key industry players, and increasing demand for precision oncology solutions. The growing prevalence of cancer and rising preference for minimally invasive treatment approaches continue to drive market growth. Moreover, continuous advancements in AI-based treatment planning and integration with imaging systems significantly contribute to sustained market expansion.

Europe SRS Treatment Planning Systems Market Insight

The Europe SRS treatment planning systems market is projected to expand at a steady CAGR throughout the forecast period, primarily driven by increasing adoption of advanced radiotherapy technologies and strong regulatory support for innovative cancer treatment solutions. Healthcare providers in the region emphasize high-quality treatment standards, patient safety, and integration of digital health technologies, fostering consistent adoption of advanced treatment planning systems across hospitals and oncology centers. Growth is further supported by rising investments in healthcare infrastructure and expanding access to precision radiotherapy.

U.K. SRS Treatment Planning Systems Market Insight

The U.K. SRS treatment planning systems market is anticipated to grow at a notable CAGR during the forecast period, supported by increasing demand for advanced cancer treatment technologies and strong focus on improving clinical outcomes. Rising adoption of digital healthcare solutions and expansion of radiotherapy services are driving demand across healthcare facilities. The country’s well-established healthcare system and increasing investments in oncology infrastructure are accelerating the adoption of advanced treatment planning systems.

Germany SRS Treatment Planning Systems Market Insight

The Germany SRS treatment planning systems market is expected to expand at a considerable CAGR during the forecast period, driven by strong focus on technological innovation and high adoption of advanced medical technologies. Germany’s emphasis on precision medicine, high-quality healthcare services, and integration of advanced imaging and radiotherapy solutions supports the widespread use of SRS treatment planning systems. Increasing investments in research and development and strong presence of leading medical technology companies further contribute to market growth.

Asia-Pacific SRS Treatment Planning Systems Market Insight

The Asia-Pacific SRS treatment planning systems market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by increasing cancer incidence, improving healthcare infrastructure, and rising investments in advanced radiotherapy technologies. Countries such as China, India, and Japan play a key role in expanding access to cancer treatment services. Rising healthcare expenditure, growing awareness regarding precision oncology, and government initiatives to strengthen cancer care infrastructure are accelerating market growth across the region.

Japan SRS Treatment Planning Systems Market Insight

The Japan SRS treatment planning systems market is gaining momentum due to strong focus on advanced medical technologies and high-quality healthcare services. Increasing adoption of precision radiotherapy and integration of advanced imaging systems are driving demand. The country’s emphasis on innovation and technological advancement supports the development and adoption of sophisticated treatment planning solutions across healthcare facilities.

India SRS Treatment Planning Systems Market Insight

The India SRS treatment planning systems market accounted for a growing share in Asia-Pacific in 2025, attributed to increasing cancer prevalence, expanding healthcare infrastructure, and rising investments in oncology care. Growing awareness regarding advanced treatment options and increasing adoption of radiotherapy technologies are driving demand. Government initiatives aimed at improving cancer care facilities and expanding access to advanced treatment technologies are key factors supporting sustained market growth in India.

SRS Treatment Planning Systems Market Share

The SRS Treatment Planning Systems industry is primarily led by well-established companies, including:

• Elekta AB (Sweden)
• Varian Medical Systems, Inc. (U.S.)
• Siemens Healthineers AG (Germany)
• Accuray Incorporated (U.S.)
• Brainlab AG (Germany)
• RaySearch Laboratories AB (Sweden)
• Philips Healthcare (Netherlands)
• GE HealthCare Technologies Inc. (U.S.)
• MIM Software Inc. (U.S.)
• IBA Worldwide (Belgium)
• Panacea Medical Technologies Pvt. Ltd. (India)
• Mevion Medical Systems (U.S.)
• ViewRay Technologies, Inc. (U.S.)
• C-RAD AB (Sweden)
• Mirada Medical (U.K.)
• DOSIsoft (France)
• Prowess Inc. (U.S.)
• Standard Imaging Inc. (U.S.)
• ScandiDos AB (Sweden)
• PTW Freiburg GmbH (Germany)

What are the Recent Developments in Global SRS Treatment Planning Systems Market?

• In December 2025, Varian Medical Systems expanded its SRS treatment planning systems portfolio by introducing an advanced AI-powered treatment planning module designed to improve dose optimization, enhance workflow efficiency, and reduce planning time in stereotactic radiosurgery procedures
• In October 2025, Elekta AB enhanced its SRS treatment planning systems by upgrading Gamma Knife planning software with improved imaging integration and precision targeting capabilities aimed at improving clinical outcomes
• In August 2025, RaySearch Laboratories AB launched a cloud-based treatment planning platform designed to enable real-time collaboration, improve scalability, and enhance data accessibility across oncology centers
• In June 2025, Brainlab AG introduced automated contouring and AI-driven planning features in its SRS treatment planning systems to streamline radiotherapy workflows and improve treatment accuracy
• In March 2024, Accuray Incorporated upgraded its CyberKnife treatment planning system with adaptive radiotherapy capabilities to enable personalized treatment adjustments and improve precision in tumor targeting

SKU-76210